All Stories

  1. Global Burden of Cardiovascular Diseases and Risks, 1990-2022

    Article • Journal of the American College of Cardiology, December 2023, Elsevier

    Gerald Chi, Shumaila Nargus, Professor Erkin Mirrakhimov, Laszlo Lorenzovici, Dr. Saurab Sharma, Ph.D., Dr. Tungki Pratama Umar, ED Doris V. Ortega-Altamirano, Dr Mohammed Kuddus, Prof Tommi Vasankari, Dr Yuan-Pang Wang, Prof. Muayyad M Ahmad, Javier Abednego Magaña Gomez, Dr Amr Hassan, Dr Ali Fatehizadeh

  2. EE720 Budget Impact of Preoperative Anemia Management, the First Pillar of Patient Blood Management, on the Romanian Healthcare System

    Article • Value in Health, December 2023, Elsevier

    Laszlo Lorenzovici

  3. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021

    Article • The Lancet Haematology, September 2023, Elsevier

    Asrat Arja Wolde, Dr Mohammed Kuddus, Dr. Ahmed I. Hasaballah, José João Baltazar Mendes, Professor Yousef Khader, Laszlo Lorenzovici, Dr Ali Fatehizadeh

  4. A Potential Indicator for Assessing Patient Blood Management Standard Implementation

    Article • Healthcare, August 2023, MDPI AG

    Laszlo Lorenzovici

  5. Recommendations for patient involvement in health technology assessment in Central and Eastern European countries

    Article • Frontiers in Public Health, July 2023, Frontiers

    Laszlo Lorenzovici

  6. Predictors of mortality for patients with hip fracture: a study of the nationwide 1-year records of 24,950 fractures in Romania

    Article • Archives of Osteoporosis, May 2023, Springer Science + Business Media

    Laszlo Lorenzovici

  7. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019

    Article • EClinicalMedicine, May 2023, Elsevier

    Professor Ovidiu Constantin Baltatu, Professor Erkin Mirrakhimov, Prof Tommi Vasankari, Dr Ali Fatehizadeh, Laszlo Lorenzovici, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE

  8. Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment

    Article • Frontiers in Public Health, April 2023, Frontiers

    Laszlo Lorenzovici

  9. Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making

    Article • Journal of Comparative Effectiveness Research, March 2023, Becaris Publishing Limited

    Laszlo Lorenzovici

  10. Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia

    Article • BioDrugs, February 2023, Springer Science + Business Media

    Laszlo Lorenzovici

  11. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026

    Article • The Lancet Global Health, January 2023, Elsevier

    Mr. Deldar Morad Abdulah, Dr Sonu Bhaskar, Professor Erkin Mirrakhimov, Professor Yousef Khader, Prof Tommi Vasankari, Dr arnaud Iradukunda, Dr Ali Fatehizadeh, José João Baltazar Mendes, Laszlo Lorenzovici, Turki Alanzi, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Morteza Saki

  12. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019

    Article • The Lancet, November 2022, Elsevier

    Dr Sonu Bhaskar, Dr Amin Mousavi Khaneghah, Additional Prof (Dr.) Paramdeep Singh, Dr. Bolajoko O. Olusanya, Professor Erkin Mirrakhimov, Professor Yousef Khader, Dr arnaud Iradukunda, Dr Ali Fatehizadeh, Laszlo Lorenzovici, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Sumaira Mubarik

  13. Prioritization of implementation barriers related to integrated care models in Central and Eastern European countries

    Article • Health Policy, November 2022, Elsevier

    Laszlo Lorenzovici

  14. Jó ötlet-e a paraszolvencia kriminalizálása?

    Article • Orvosi Hetilap, October 2022, Akademiai Kiado

    Laszlo Lorenzovici

  15. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019

    Article • The Lancet, August 2022, Elsevier

    Dr Amin Mousavi Khaneghah, Andrew T. Olagunju, Dr Mohammad Hosein Amirzade-Iranaq, Dr Aidin Abedi, Dr Md Nuruzzaman Khan, Additional Prof (Dr.) Paramdeep Singh, Dr Ali Fatehizadeh, Dr. Ahmed I. Hasaballah, Dr/ Adj Prof Vijay Kumar Chattu, Assistant Professor Ashok Pandey, Laszlo Lorenzovici, Turki Alanzi, Sumaira Mubarik, Dr Javad Sharifi Rad

  16. Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019

    Article • The Lancet Infectious Diseases, August 2022, Elsevier

    Professor Yousef Khader, Andrew T. Olagunju, Dr. Le Huu Nhat Minh, Dr Md Nuruzzaman Khan, Additional Prof (Dr.) Paramdeep Singh, Dr Ali Fatehizadeh, Dr. Ahmed I. Hasaballah, Dr/ Adj Prof Vijay Kumar Chattu, Dr. Saif Aldeen S AlRyalat, Laszlo Lorenzovici, Dr Agha Zeeshan Mirza, Sumaira Mubarik

  17. Riding the Pandemic Waves—Lessons to Be Learned from the COVID-19 Crisis Management in Romania

    Article • Tropical Medicine and Infectious Disease, June 2022, MDPI AG

    Laszlo Lorenzovici

  18. Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019

    Article • The Lancet Public Health, June 2022, Elsevier

    Dr Yuan-Pang Wang, Morteza Saki, Dr Sonu Bhaskar, Professor Yousef Khader, Andrew T. Olagunju, Dr Amr Hassan, Professor Tarek Tawfik Amin, Mr. Deldar Morad Abdulah, Dr Aidin Abedi, Dr Md Nuruzzaman Khan, Additional Prof (Dr.) Paramdeep Singh, Professor Erkin Mirrakhimov, Dr Amin Mousavi Khaneghah, Asrat Arja Wolde, Dr Ali Fatehizadeh, Dr. Ahmed I. Hasaballah, Dr/ Adj Prof Vijay Kumar Chattu, Laszlo Lorenzovici, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Sumaira Mubarik, Abay Woday Tadesse

  19. Burden of Chronic Heart Failure in Romania

    Article • Healthcare, January 2022, MDPI AG

    Laszlo Lorenzovici

  20. POSA238 Hospital Length of Stay and Antibiotic Prescription Practices for Patients Diagnosed with Gram Negative Infections - Evidence from Hospitals in Romania

    Article • Value in Health, January 2022, Elsevier

    Laszlo Lorenzovici

  21. Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges

    Article • Frontiers in Public Health, January 2021, Frontiers

    Guenka Petrova, Laszlo Lorenzovici

  22. Cost Assessment of Inpatient Care Episodes of Stroke in Romania

    Article • Frontiers in Public Health, December 2020, Frontiers

    Laszlo Lorenzovici

  23. PND18 Treatment Cost of Ischemic Stroke Inpatient Admissions in Romanian Public Hospitals

    Article • Value in Health, December 2020, Elsevier

    Laszlo Lorenzovici

  24. Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries

    Article • Frontiers in Pharmacology, June 2020, Frontiers

    Laszlo Lorenzovici

  25. Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure and Iron Deficiency in Romania

    Article • Journal Of Cardiovascular Emergencies, December 2019, De Gruyter

    Marcell Csanádi, Laszlo Lorenzovici

  26. The implications of external price referencing on pharmaceutical list prices in Europe

    Article • Health Policy and Technology, September 2018, Elsevier

    Laszlo Lorenzovici

  27. Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts

    Article • BioMed Research International, January 2018, Hindawi Publishing Corporation

    Guenka Petrova, Marcell Csanádi, prof Vitaly Vladimirovich Omelyanovskiy , Laszlo Lorenzovici

  28. Policy Practices to Maximise Social Benefit from Biosimilars

    Article • Journal of Bioequivalence & Bioavailability, January 2017, OMICS Publishing Group

    Laszlo Lorenzovici

  29. Mapping of The Biosimilar Drug Policy in 10 Central Eastern European Countries

    Article • Value in Health, November 2016, Elsevier

    Guenka Petrova, Laszlo Lorenzovici

  30. Implication Of External Price Referencing On Pharmaceutical List Prices In Europe

    Article • Value in Health, November 2016, Elsevier

    Laszlo Lorenzovici

  31. Economic Evaluation of Ulipristal Acetate for the Treatment of Patients With Moderate and Severe Symptoms of Uterine Fibroids in Romania

    Article • Value in Health, November 2014, Elsevier

    Laszlo Lorenzovici